Dupixent and Narrowband UVB for Atopic Dermatitis

Inclusion Criteria:

Male or female adult ≥ 18 years of age;

Diagnosis of moderate to severe atopic dermatitis as defined at baseline by:

EASI score of 16 or greater,
IGA score of 3 or greater
BSA of 10% or greater,

Exclusion Criteria:

Subjects with previous exposure to dupilumab.
Known or suspected hypersensitivity to dupilumab or any of its excipients.
History of photosensitivity.